| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |